4//SEC Filing
To Lucy 4
Accession 0000950170-24-096405
CIK 0001833214other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:00 PM ET
Size
5.7 KB
Accession
0000950170-24-096405
Insider Transaction Report
Form 4
To Lucy
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2024-08-12+125,000→ 125,000 totalExercise: $2.35Exp: 2034-08-12→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan, as amended.
- [F2]The shares underlying the option vest over a four-year period, with 1/4 vesting on the one-year anniversary date from the Reporting Person's commencement of service as Chief Financial Officer (August 12, 2025), and the remainder vesting thereafter in equal monthly installments over a three year period.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0002032049
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 5:00 PM ET
- Size
- 5.7 KB